stars 1 stars 2 stars 3

Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI. We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.

Website http://www.evotec.com
Ticker EVT
Revenue $800.4 million
Funding $604 million
Employees 4,783 (2,542 on RocketReach)
Founded 1993
Address Manfred Eigen Campus, Essener Bogen 7, Hamburg, Hamburg 22419, DE
Phone +49 40 560810
Fax +49 40 56081222
Technologies
Industry Biotechnology Research, Drug Manufacturing & Research, Biopharma, CNS, Oncology, Pharmaceuticals, Biotechnology, Pain, Healthcare, Health Care, Neurosciences, Science and Engineering, Inflammation, Neuroscience, Metabolic disease, Pharmaceutical, Infection
Web Rank 868071
Keywords Drug Discovery, Drug Development, Drug Research, Biotechnology, Pharmaceutical Development, Research And Development, Biotechnology Research, Drug Design, Biopharma, Pharmaceutical Research, Therapeutic Discovery, Life Sciences, Clinical Trials, Contract Research Organization, Pharmaceutical Services, Clinical Research, Biological Research, Medicinal Chemistry, Biologics, Preclinical Development
Competitors Syneos Health, Parexel, UCB, Medpace, WuXi AppTec, Covance, Quotient Sciences, Sygnature Discovery, Insilico Medicine, CRL design +40 more (view full list)
SIC SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies
NAICS NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies

Evotec Questions

The Evotec annual revenue was $800.4 million in 2026.

Christian Wojczewski is the CEO of Evotec.

2,542 people are employed at Evotec.

Evotec is based in Hamburg, Hamburg.

The NAICS codes for Evotec are [32541, 325, 3254, 32].

The SIC codes for Evotec are [283, 28, 2834].

Top Evotec Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users